mitoquinol
Small moleculeexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2018 (NCT03586414)
Timeline
Indications
Mechanism of action
- Unspecified targetAntioxidant
antioxidant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05410873 | Phase 2 | Jul 26, 2022 | British Heart Foundation, Imperial College London |
| NCT04026711 | Phase 1 | Sep 1, 2019 | Duke University, University of Vermont |
| NCT03586414 | N/A | Sep 30, 2018 | University of Colorado, Denver |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| British Heart Foundation | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Imperial College London | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Colorado, Denver | Academic/Hospital | 1 | 1 | 1 | 2018 |
| University of Vermont | Academic/Hospital | 1 | 1 | 1 | 2019 |
5 organizations
Page 1 / 1